Table S2 from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
收藏NIAID Data Ecosystem2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/Table_S2_from_Phase_II_Clinical_Trial_of_Everolimus_in_a_Pan-Cancer_Cohort_of_Patients_with_mTOR_Pathway_Alterations/22480325
下载链接
链接失效反馈官方服务：
资源简介：
Table S2. Demographic and clinical characteristics of 30 cancer patients with mTOR pathway mutations. S2.1. Master table showing a summary of demographic characteristics and clinical outcomes. S2.2. Prior systemic treatment regimens. S2.3. Objective response to everolimus according to RECIST v1.1 criteria. S2.4. Toxicity profile of patients according to CTCAE v4.0.
创建时间：
2021-07-15
